Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan and systemic inflammatory parameters in patients with arterial hypertension and asymptomatic coronary artery disease
2006-002290-52Phase 4Active
- Sponsor
- Universitätsklinikum Erlangen
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of telmisartan in hypertensive disease (HTN) and coronary arteriosclerosis, sponsored by Universitätsklinikum Erlangen. Primary endpoint: Change in systemic inflammatory parameters after 6 months of telmisartan treatment. Started Sep 2007; status: active.
02
Drugs
telmisartan
03
Conditions
hypertensive disease (HTN)coronary arteriosclerosis
Beyond the preview
Go deeper on 2006-002290-52.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002290-52.